The Cancer Institute is focused on the team approach to patient care. A multidisciplinary health care team, specially trained in diagnosis and treatment of all aspects for various hematological malignancies, nonmalignant acquired bone marrow disorders, genetic diseases that are associated with abnormal hematopoiesis and function, bleeding disorders, bone marrow transplantation, sickle cell anemia, and solid tumors. Patients benefit from the combined expertise contributed by a comprehensive array of specialists that meet weekly to discuss patient care plans and optimal treatment options.
The Cancer Institute’s approach is simple — discovery in our labs, development of new treatment strategies and delivery of these new strategies to our clinics. Cancer Institute research moves from the laboratory bench to our patient’s bedside. The bottom line for our patients is that our research fuels innovative treatment options.
The Cancer Institute and the Myeloma Institute have made and continue to uncover scientific advances that translate into therapy:
- Only Adult Allogeneic Stem Cell Transplant team in Arkansas
- Only Adult Sickle Cell Clinic in Arkansas
- First bone marrow transplant in Arkansas
- First to initiate use of tandem stem cell transplants
- First outpatient stem cell transplant (autologous)
- First stem cell transplant for patients over the age of 70
- Initiation of idiotype and dendritic cell vaccines
- Creation of stem cell purification process